Skip to main content

Joanne Kurtzberg, MD

Jerome S. Harris Distinguished Professor of Pediatrics
Professor of Pediatrics
Professor of Pathology
Core Faculty in Innovation & Entrepreneurship
Member of the Duke Cancer Institute
Affiliate of the Regeneration Next Initiative
Campus mail: 2400 Pratt Street, DUMC Box 102501, Durham, NC 27710
Phone: (919) 668-1100
Email address: kurtz001@mc.duke.edu

Dr. Kurtzberg conducts both clinical and laboratory-based translational research efforts, all involving various aspects of normal and malignant hematopoiesis. In the laboratory, her early work focused on studies determining the mechanisms that regulate the choice between the various pathways of differentiation available to the pluripotent hematopoietic stem cell. Her laboratory established a CD7+ cell line, DU.528, capable of multilineage differentiation as well as self-renewal, and subsequently described the aggressive leukemic syndrome of CD7+ALL and demonstrated that a normal counterpart of the CD7+, TN malignant cell can be isolated from postnatal human thymus, bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood progenitor cells. The leukemic CD7+ cell has been established in model systems nude and SCID mice where direct IL2-cytotoxicity has been demonstrated. The mechanism of IL2-induced cytotoxicity is currently a major focus of work in the laboratory. One focus of Dr. Kurtzberg's translational research is the use of novel deoxynucleosides to purge normal and malignant T-cells from human bone marrow. She has also played an important role in the development of PEG-L Asparaginase and Nelarabine, two novel antileukemia drugs that are now used routinely in the clinic. Dr. Kurtzberg is active in the Children's Oncology Group and coordinated the ALinC 16 high risk study for children with newly diagnosed B-lineage acute lymphoblastic leukemia (ALL) as well as relapsed studies for children with T- and B-lineage ALL. Under Dr. Kurtzberg's leadership, Duke has established an internationally known children's transplant program which currently treats children with cancer, blood disorders, immune deficiencies, hemoglobinopathies and inherited metabolic diseases. Over the past 2 years, the cord blood transplant program at Duke has initiated studies of autologous cord blood in children with neonatal brain injury and cerebral palsy. Dr. Kurtzberg’s laboratory is also pursuing preclinical studies isolating oligodendrocytes from cord blood with the goal of using these cells for cell therapy to treat acquired agenetic brain injuries in the next few years. Over the past 2 decades, Dr. Kurtzberg pioneered and is investigating the use of banked umbilical cord blood as an alternative stem cell source for unrelated marrow transplantation. She was awarded with a banking and transplant center contract from NHLBI for 1996-2005, to establish the Carolinas Cord Blood Bank (CCBB)at Duke and was the PI on the cord blood transplantation study (COBLT) in children with hematological malignancies and inborn errors of metabolism. In 2006, the CCBB was awarded a contract from HRSA to become a member bank of the National Cord Blood Inventory (NCBI) of the CW Bill Young Cell Transplantation Program after legislation was passed in 2005 to establish this network. Dr. Kurtzberg is also the Duke PI for the NIH-sponsored, Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) and the PI on a national trial comparing single and double cord blood transplantation in children with hematological malignancies. In 2008-2009, Dr. Kurtzberg’s lab pioneered studies to predict cord blood potency through novel assays on segments attached to cryopreserved cord blood units. The program is also performing translational research testing cord blood expansion, cellular targeted therapies and tissue repair and regeneration.

Education and Training

  • M.D., New York University, 1976

Selected Grants and Awards

Publications

Kurtzberg, Joanne. “The view for cord blood is "cup half full" not "cup half empty".” Stem Cells Transl Med, July 3, 2020. https://doi.org/10.1002/sctm.20-0260.

Full Text

Simhal, Anish K., Kimberly L. H. Carpenter, Saad Nadeem, Joanne Kurtzberg, Allen Song, Allen Tannenbaum, Guillermo Sapiro, and Geraldine Dawson. “Measuring robustness of brain networks in autism spectrum disorder with Ricci curvature.” Sci Rep 10, no. 1 (July 2, 2020): 10819. https://doi.org/10.1038/s41598-020-67474-9.

Full Text

Dawson, Geraldine, Jessica M. Sun, Jennifer Baker, Kimberly Carpenter, Scott Compton, Megan Deaver, Lauren Franz, et al. “A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder.” J Pediatr 222 (July 2020): 164-173.e5. https://doi.org/10.1016/j.jpeds.2020.03.011.

Full Text

Sun, Jessica M., Geraldine Dawson, Lauren Franz, Jill Howard, Colleen McLaughlin, Bethany Kistler, Barbara Waters-Pick, Norin Meadows, Jesse Troy, and Joanne Kurtzberg. “Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder.” Stem Cells Transl Med, June 12, 2020. https://doi.org/10.1002/sctm.19-0434.

Full Text

Miyadera, Keiko, Laura Conatser, Telmo A. Llanga, Kendall Carlin, Patricia O’Donnell, Jessica Bagel, Liujiang Song, et al. “Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I.” Mol Ther 28, no. 6 (June 3, 2020): 1455–63. https://doi.org/10.1016/j.ymthe.2020.04.004.

Full Text

Guenzel, Adam J., Coleman T. Turgeon, Kim K. Nickander, Amy L. White, Dawn S. Peck, Gisele B. Pino, April L. Studinski, et al. “The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.” Genet Med 22, no. 6 (June 2020): 1108–18. https://doi.org/10.1038/s41436-020-0764-y.

Full Text

Qu, Wenchun, Zhen Wang, Joshua M. Hare, Guojun Bu, Jorge M. Mallea, Jorge M. Pascual, Arnold I. Caplan, et al. “Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.” Stem Cells Transl Med, May 29, 2020. https://doi.org/10.1002/sctm.20-0146.

Full Text

Hong, Xinying, Arun Babu Kumar, Jessica Daiker, Fan Yi, Martin Sadilek, Fabiola De Mattia, Francesca Fumagalli, et al. “Leukocyte and Dried Blood Spot Arylsulfatase A Assay by Tandem Mass Spectrometry.” Anal Chem 92, no. 9 (May 5, 2020): 6341–48. https://doi.org/10.1021/acs.analchem.9b05274.

Full Text

Kurtzberg, Joanne, Hisham Abdel-Azim, Paul Carpenter, Sonali Chaudhury, Biljana Horn, Kris Mahadeo, Eneida Nemecek, et al. “A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease.” Biol Blood Marrow Transplant 26, no. 5 (May 2020): 845–54. https://doi.org/10.1016/j.bbmt.2020.01.018.

Full Text

Valente, L. A., L. R. Begg, A. R. Anderson, T. Segura, A. Rudisill, J. Kurtzberg, and A. J. Filiano. “Developing a novel thymus organoid as a cell therapy to correct autoimmunities.” In Cytotherapy, 22:S138–S138, 2020.

Scholars@Duke

Pages